SCHEMBL8556952

SCHEMBL8556952

[CH2]Cc1ccc(OCc2ccccc2)c(OC)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NPC1 O15118 3/20 0.59
RAB9A P51151 3/20 0.59
KDM4E B2RXH2 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
BLM P54132 1/20 0.59
ABCB1 P08183 1/20 0.57
ABCG2 Q9UNQ0 1/20 0.57
BCHE P06276 1/20 0.56
HPGD P15428 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
MTNR1A P48039 2/20 0.55
MTNR1B P49286 2/20 0.55
ALDH1A1 P00352 1/20 0.55
MAPT P10636 1/20 0.55
HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8554816 0.94 MAPK1 (0.59) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL7208378 0.90 SLC2A1 (0.52) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL8306114 0.88 KDM4E (0.64) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL5653057 0.85 NPC1 (0.64) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL13917946 0.85 ABCB1 (0.62) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL3712764 0.84 MEN1 (0.60) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL31725848 0.84 NPC1 (0.63) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL28497415 0.84 MEN1 (0.60) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL698056 0.84 NPC1 (0.63) MEN1KMT2ANPC1RAB9AKDM4E
SCHEMBL3232932 0.84 MEN1 (0.64) MEN1KMT2ANPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0617022-B1 6,7, dialkoxy-3,4-dihydroisoquinolin-8-ol, process for preparation thereof and process for preparation of 6,7-dialkoxy-1,2,3,4-tetrahydroisoquinolin-8-ol using the compound BANYU PHARMA CO LTD (JP) 1998-02-11 EP disclosed
US-5498717-A CHEMICAL INTERMEDIATES FOR PRODUCING ANTITUMOR POTENTIATORS BANYU PHARMACEUTICAL CO., LTD. (JP) 1996-03-12 US disclosed
US-5446164-A Regioselective cyclization of phenethylamide derivative in presence of phosphoric acid halide, reducing formed compound BANYU PHARMACEUTICAL CO., LTD. (JP) 1995-08-29 US disclosed